Determinants of Treatment Delays Among Underserved Hispanics With Lung and Head and Neck Cancers
Determinants of Treatment Delays Among Underserved Hispanics With Lung and Head and Neck Cancers
复制标题
DOI：
10.1177/107327481602300410
复制
发表时间：
2016-10-01
期刊：
影响因子：
2.6
通讯作者：
Nguyen, Jennifer
中科院分区：
文献类型：
--
作者：
Borrayo, Evelinn A.;Scott, Katie L.;Nguyen, Jennifer
背景资料：缺乏证据来解释为什么在被诊断患有肺癌和头颈癌的弱势西班牙裔患者中治疗被延迟的原因。数据表明，治疗延迟超过46天会增加这些癌症患者的死亡风险。方法：采用混合方法设计，通过分析40名西班牙裔患者的病历数据和29名西班牙裔患者、护理人员、医疗保健专业人员和安全网医院的患者导航员的访谈数据，探索治疗延迟的决定因素。在40名西班牙裔患者中，35%在确诊后46天或更长时间开始治疗，但女性比男性延迟更长时间（平均48天）。患有少数共病的女性（
Background: Evidence is lacking to explain the reasons why treatment is delayed among disadvantaged Hispanic patients diagnosed with lung and head and neck cancers. Data indicate that treatment delays beyond 46 days increase the risk of death for individuals with these cancers.Methods: A mixed-methods design was used to explore determinants of treatment delays by analyzing data from the medical records of 40 Hispanic patients and data from interviews with 29 Hispanic patients, care-givers, health care professionals, and patient navigators from a safety-net hospital.Results: Of the 40 Hispanic patients, 35% initiated treatment 46 days or more after being diagnosed, but women experienced longer delays than men (average of 48 days). Women with few comorbid diseases (